drugset / Trial / NCT01702194
TD-1211 IV/Oral Mass Balance Study
Non-randomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to determine TD-1211 is processed by the body.
Timeline
- Start
- 2012-11
- Primary completion
- 2013-02
- Completion
- 2013-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | axelopran | Small molecule | — | Intravenous |